CompaniesByCap
URGN
Urogen Pharma Ltd. (URGN)
NASDAQ · Healthcare

Urogen Pharma Ltd. Income Statement 2016–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
Revenues
Revenue109.8M90.4M82.7M64.4M48.0M11.8M18,0001.1M8.2M17.5M
Gross Profit97.3M81.5M73.4M56.7M42.9M10.8M18,000-675,0007.6M17.5M
Profitability
Operating Income-124.9M-96.8M-65.5M-79.0M-92.3M-126.7M-109.5M-77.2M-19.9M798,000
EBITDA
Net Income-153.5M-126.9M-102.2M-109.8M-110.8M-128.5M-105.1M-75.7M-20.0M-1.9M
Per Share Data
EPS (diluted)
Shares Outstanding (dil.)48M42M32M23M22M22M21M16M14M

Urogen Pharma Ltd. Income Statement — FAQ

Urogen Pharma Ltd. (URGN) income statement over the last 10 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see URGN's income statement history?

The chart and table above show Urogen Pharma Ltd.'s income statement by year and by quarter, including the growth rate.